The global eClinical solutions market was valued at USD 5.9 Billion in 2019 and expected to reach USD 16.36 Billion by 2027 and poised to grow at a compound annual growth rate (CAGR) 13.6% during the forecast period 2020 to 2027.
Integration of software solutions in clinical trials provides tremendous market growth. Further, rising trend of clinical trial outsourcing services to Contract Research Organizations (CROs) coupled with rising number of life sciences organizations and CROs poised to help the market to gain significant traction over the forecast period. Increasing research activities in Asian countries for the development of cost-effective solutions or modules expected to spur the market growth.
Presence of strict regulations for clinical trial together with rising need for safety monitoring plays a vital role in the fuelling adoption of eClinical solutions especially in the developed countries such as the United States. For instance, the National Institutes of Health and the U.S. Department of Health and Human Services have issued stringent regulations on clinical trial registration requirements; additionally they promote clinical data sharing.
Biopharma and pharma companies seeks surge in demand of software solutions for clinical trials that accounts as one of the primary factor to stimulate the overall market growth. Apart from this, favorable government policies to expand the end-users of eClinical solutions as well as offer grants to substantiate trials are likely to propel the market growth during the analysis period.
Electronic Clinical Outcome Assessment (eCOA) estimated as the fastest growing product segment during the forecast period due to rising importance of high-quality clinical data. eCOA enables preservation of overall quality and is being largely integrated in the measurement of clinician-reported, patient-reported, and observer-reported outcomes. Data capturing process via eCOA platforms enhances the streamlines data collection procedures, quality of information captured, and also offers an effective data analysis.
Delivery Mode Insights
Web-hosted eClinical solutions captured maximum market value share in 2019. The dominance of the segment is mainly due to its associated benefits that include usability, easy accessibility, and lower investments required. Further, the web-hosted solutions can be easily customized because of which providers can customize their offering as per the user group. Further, these solutions have higher level of interoperability. The aforementioned factors help the segment to maintain its position during the forecast period.
However, Cloud-based solutions predicted to exhibit strong growth rate during the analysis period due to integrated features such as negligible handling costs, high accessibility, flexibility, and easy data backup. Real-time data obtained through these systems that enable users to make quick decisions along with it also provides high-quality information for risk monitoring. The above associated advantages projected to bolster the demand for cloud-based solutions during the forecast period.
In 2019, CROs dominated the global eClinical solutions market and anticipated to witness remarkable growth in the coming years. This is attributed to the rising concern of pharmaceutical companies to reduce their overall expenditure. Moreover, increasing application of eClinical solutions in research activities has further broadened the scope of the segment. Benefits of outsourcing clinical trials to CROs comprise enhanced productivity, increased efficiency of services, cost advantages, and increased focus on core areas of development that are critical for a company’s growth.
On the other hand, pharmaceutical and biotechnology companies expected to witness prominent growth over the forecast period. The eClinical solutions not only enhances the efficiency of the trial but also reduce the time and cost required during a drug development.
North America led the global eClinical solutions market in terms of revenue in the year 2019. Rising prevalence of lifestyle accompanied with several diseases such as cardiac disorder and diabetes along with increasing number of target population are the key factors that poised to stimulate the demand of eClinical solutions in the region. Apart from this, the Asia Pacific exhibits lucrative growth over the analysis period owing to rising prevalence of chronic diseases that include cardiovascular conditions, cancer, and infectious diseases. Furthermore, many Asian countries such as India, China, Japan, and Korea outsources large number of clinical trials due to large patients population in the countries, thereby boosting the adoption of eClinical solutions in above mentioned regions.
Key Companies & Market Share Insights
The global eClinical solutions market encounters huge competition among the market players owing to a race among players to capture the untapped market opportunity. These players adopt various growth strategies that are mergers & acquisitions, new product development, and collaborations that help them to consolidate their position in the market. For example, in September 2019, Anju Software Inc. acquired OmniComm Systems to enrich its portfolio of eClinical solutions with innovative data analytical capabilities.
Some of the prominent players in the eClinical solutions market include:
Segments Covered in the Report
This research study comprises complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers classification of marketplace into impending and niche sectors. Further, this research study calculates market size and its development drift at global, regional, and country from 2016 to 2027. This report contains market breakdown and its revenue estimation by classifying it on the basis of product, development phase, delivery mode, end-use, and region:
By Development Phase
By Delivery Mode
By Regional Outlook
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client